Early-Stage Venture Financing (Creative Destruction Lab)

Summary

• The paper analyzes early-stage venture financing choices between equity and non-priced instruments such as SAFEs or convertible notes.p.1
• Empirical analysis is conducted on a dataset of 500 financing rounds from startups associated with the Creative Destruction Lab.p.1
• In the analyzed sample, pre-seed financing rounds raised an average size of $250 thousand.p.6
• Seed financing rounds raised an average of $2 million to finance initial R&D and product development.p.6
• Series A financing rounds involved significantly larger amounts, averaging $11 million per round.p.7

Key insights

1. High-quality startups prefer SAFEs over equity because share conversion terms are set after the market observes clearer performance signals.p.1
2. SAFE financing introduces a moral-hazard or debt-overhang cost that can distort future investment decisions.p.1
3. Debt financing represents virtually zero share of early-stage venture financing due to pre-revenue status and rigid repayment terms.p.2
4. The proportion of non-priced financing decreases as startups move to later stages like Series A and B.p.23
5. Smaller financing rounds rely more heavily on non-priced instruments to avoid high fixed valuation and due diligence costs.p.23
6. Bridge financing rounds rely heavily on non-priced instruments, particularly convertible notes, to prevent valuation mispricing before major equity rounds.p.24
7. Introducing SAFEs can surprisingly lower total market efficiency by reducing second-period investments among switching firms due to debt overhang.p.21
8. Valuation caps in SAFEs act as contingent call options that strengthen angel investors' incentives to provide advisory support.p.30